StockWatch
·
Pharmaceuticals
Quarterly Result23 Jul 2026, 01:06 pm

Novartis India Q1 FY27 Profit ₹322.1 Mn

AI Summary

Novartis India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a Profit After Tax (PAT) of ₹322.1 million, an increase from ₹276.2 million in the same quarter last year. Total income for the quarter stood at ₹1,725.5 million. Expenses were reported at ₹693.8 million. The company also disclosed that it has a single operating segment, 'Pharmaceutical Business', and operates solely within India. There were no deviations or defaults on loans and debt securities, and related party transactions were not applicable for this filing. The results have been subjected to a limited review by the statutory auditors.

Key Highlights

  • Q1 FY27 Profit After Tax (PAT) reported at ₹322.1 million.
  • Total income for the quarter was ₹1,725.5 million.
  • No outstanding defaults on loans or debt securities.
  • Results are unaudited and have undergone a limited review.
  • Company operates in a single segment: Pharmaceutical Business.